Kumar A - Search Results

1

Bisphosphonates in multiple myeloma: an updated network meta-analysis.

Mhaskar R, Kumar A, Miladinovic B, Djulbegovic B. Mhaskar R, et al. Among authors: kumar a. Cochrane Database Syst Rev. 2017 Dec 18;12(12):CD003188. doi: 10.1002/14651858.CD003188.pub4. Cochrane Database Syst Rev. 2017. PMID: 29253322 Free PMC article. Review.

2

Why evidence based oncology management.

Kumar A, Djulbegovic B. Kumar A, et al. J Oncol Manag. 2002 Nov-Dec;11(6):13-6. J Oncol Manag. 2002. PMID: 12502287 No abstract available.

3

Nonmyeloablative allogeneic stem-cell transplantation for hematologic malignancies: a systematic review.

Djulbegovic B, Seidenfeld J, Bonnell C, Kumar A. Djulbegovic B, et al. Among authors: kumar a. Cancer Control. 2003 Jan-Feb;10(1):17-41. doi: 10.1177/107327480301000104. Cancer Control. 2003. PMID: 12598853 Free article. Review.

4

Management of multiple myeloma: a systematic review and critical appraisal of published studies.

Kumar A, Loughran T, Alsina M, Durie BG, Djulbegovic B. Kumar A, et al. Lancet Oncol. 2003 May;4(5):293-304. doi: 10.1016/s1470-2045(03)01077-5. Lancet Oncol. 2003. PMID: 12732167 Review.

5

Bad reporting does not mean bad methods for randomised trials: observational study of randomised controlled trials performed by the Radiation Therapy Oncology Group.

Soares HP, Daniels S, Kumar A, Clarke M, Scott C, Swann S, Djulbegovic B; Radiation Therapy Oncology Group. Soares HP, et al. Among authors: kumar a. BMJ. 2004 Jan 3;328(7430):22-4. doi: 10.1136/bmj.328.7430.22. BMJ. 2004. PMID: 14703540 Free PMC article.

6

Evaluation of new treatments in radiation oncology: are they better than standard treatments?

Soares HP, Kumar A, Daniels S, Swann S, Cantor A, Hozo I, Clark M, Serdarevic F, Gwede C, Trotti A, Djulbegovic B. Soares HP, et al. Among authors: kumar a. JAMA. 2005 Feb 23;293(8):970-8. doi: 10.1001/jama.293.8.970. JAMA. 2005. PMID: 15728168 Free PMC article.

7

Are experimental treatments for cancer in children superior to established treatments? Observational study of randomised controlled trials by the Children's Oncology Group.

Kumar A, Soares H, Wells R, Clarke M, Hozo I, Bleyer A, Reaman G, Chalmers I, Djulbegovic B; Children's Oncology Group. Kumar A, et al. BMJ. 2005 Dec 3;331(7528):1295. doi: 10.1136/bmj.38628.561123.7C. Epub 2005 Nov 18. BMJ. 2005. PMID: 16299015 Free PMC article.

8

What kind of evidence do patients and practitioners need: evidence profiles based on 5 key evidence-based principles to summarize data on benefits and harms.

Djulbegovic B, Soares HP, Kumar A. Djulbegovic B, et al. Among authors: kumar a. Cancer Treat Rev. 2006 Nov;32(7):572-6. doi: 10.1016/j.ctrv.2006.06.006. Epub 2006 Aug 17. Cancer Treat Rev. 2006. PMID: 16914268 No abstract available.

9

Evidence profiles for colo-rectal cancer: benefit/harms data based on the totality of randomized evidence.

Kumar A, Soares HP, Djulbegovic B. Kumar A, et al. Cancer Treat Rev. 2006 Nov;32(7):577-80. doi: 10.1016/j.ctrv.2006.06.005. Epub 2006 Aug 21. Cancer Treat Rev. 2006. PMID: 16919883 No abstract available.

10

Myeloma (multiple).

Kumar A, Djulbegovic B. Kumar A, et al. Clin Evid. 2006 Jun;(15):1-29. Clin Evid. 2006. PMID: 16973003 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31,995 results

Search Page

Filters